Physician profile
Robert C Messinger
NPI 1669470324
$953.82
in general payments reported to CMS, 2019-2025
12 companies · $204 in 2025
The $204 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $42.22 · 2023: $16.00 · 2024: $479 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $698.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $246.38 | 2019-2024 | Acuvue |
| Sun Pharmaceutical Industries INC. | $105.89 | 2024 | |
| Mallinckrodt Hospital Products INC. | $105.87 | 2025 | Acthar |
| Genzyme Corporation | $102.77 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $97.85 | 2025 | Xdemvy |
| Biotissue Holdings INC. | $59.85 | 2024 | |
| Lkc Technologies, INC. | $58.52 | 2024 | |
| Amgen INC. | $51.67 | 2024 | Tepezza |
| Aerie Pharmaceuticals, INC. | $42.22 | 2020 | |
| Optos, INC. | $36.41 | 2019 | |
| Visioneering Technologies, INC. | $30.39 | 2019 | |
| Alcon Vision LLC | $16.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Messinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.